Alina® disposable pen injector platform | Stevanato Group - Stevanato Group
Alina is a user-friendly disposable pen-injector platform for diabetes care, based on proven technology. Alina® pen-injector for diabetes and weight management
Home - Managing Complexity, Delivering Value - Stevanato Group > Products & Capabilities - Stevanato Group > Drug delivery systems for biopharma | Stevanato Group - Stevanato Group > Alina® disposable pen injector platform | Stevanato Group - Stevanato Group
page-wrapper

Alina® is a variable-dose pen injector that we developed based on Axis-D intellectual property and technology, exclusively licensed from pen injector device expert Haselmeier. The pen injector’s performance, features, and intuitive handling are compatible with established therapeutic regimens as well as innovative drug therapies that require a multi-dose delivery device, such as diabetes and weight management.

SG Alina - Pen Injector
SG Alina - Pen Injector
SG Alina- Pen Injector
SG Alina- Pen Injector

The trademark Alina is a registered right exclusively owned by Stevanato Group or its affiliates.

Customizable and Scalable Pen Injector for Your Pharmaceutical Needs

Features

Alina® features an appealing and functional design, including an easy-to-dial mechanism, optimized injection force for patient comfort, and a readable display. This platform pen injector offers a range of customizations, from dosing and color selection to a more customized industrial design based on the needs of the pharmaceutical client.

Pen Specifications
324 dialed dose alina

Clear pre-injection dose indication to avoid underdosing

326 Pen needle

Device compatible with standard pen needles

328_dose error correction

Dose error correction possible with simple dial back

214A_Feedback 2

Visual and audible feedbacks for dose setting, correction and injection

Therapeutic Areas
235 Diabetes

Diabetes care

(Insulin and GLP-1)

406 Excessweight

Weight Management

199 Chemical Molecule

Other therapeutic areas
(e.g. cardiovascular disease, gastrointestinal disorders, pain management, neurological disorders, arthritis)

Alina® - Our Production-Ready Pen Injector Platform

The pen injector is manufactured at Stevanato Group’s FDA-inspected facility in Germany. Access to tooling and sub-assembly equipment is available to clients who are looking to balance investments for their device programs and minimize time-to-market. Dedicated production tooling and lines are available if requested due to customization considerations or to support overall risk mitigation strategies.

A range of final assembly equipment for this pen injector from our operations in Denmark and Italy can be made available to clients upon request or we can work with your existing equipment partner. Support from our glass primary container experts to final assembly and packing solutions is offered.

An Integrated Offering for Pen Injectors

89 Filled Cartridge
3mL glass cartridge available in EZ-fill® or bulk
66 Surface Characterization
Characterization of primary container closure system
196A Injection Molding
Precision manufacturing including molding, tooling and assembly of components
267A_SVMArm_Pen Alina
Sub-assembly and final assembly equipment available
275 Projectmanagement
Technology and intellectual property licensed from partner Haselmeier with additional support from our internal R&D team
Alina®’s Efficient Production for Optimized Supply Chain Management
89 Filled Cartridge

Suitable for ISO 3mL glass cartridges, and optimized for Stevanato Group’s Nexa® cartridges

325 User contact alina

A range of supportive studies are available

13 Quality

Design for manufacturing and ease of final assembly have been considered

331 Pen Injector Volume Scale

Standard volume scale on cartridge holder available

329A_Alina custom 2.eps

Additional customization can be offered

267A_SVMArm_Pen Alina

Precise piston positioning during end-assembly

25 Regulatory Expertise

Testing and verification according to ISO 11608-1:2022

Alina® Pen Injector Brochure

Alina® Press Releases and articles

Press Release 2022

Stevanato Group extends pen injector technology licensing agreement with Haselmeier

Press Release 2021

Stevanato Group to showcase the benefits of an integrated solutions approach at CPhI Worldwide Conference, November 9-11

Article: A flexible platform device to streamline market launches

Tailoring GLP-1 Biosimilar Delivery Systems for the Growing Obesity Market
WATCH THE WEBINAR
WEBINAR
webinar
ON DEMAND
Tailoring GLP-1 Biosimilar Delivery Systems for the Growing Obesity Market
53 MIN.
- ENGLISH
ON DEMAND
WEBINAR
Tailoring GLP-1 Biosimilar Delivery Systems for the Growing Obesity Market
Interested in Alina® Pen Injector?
Submit your request
We value your feedback
It helps us improve accessibility and your experience